Security Snapshot

Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) Institutional Ownership

CUSIP: 12233L107

13F Institutional Holders and Ownership History from Q2 2020 to Q4 2024

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
Symbol
BNR on Nasdaq
Shares outstanding
9,036,176
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share is tracked under CUSIP 12233L107.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 1 to 0 between Q3 2024 and Q4 2024.
  • Reported value moved from $64,484 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

12233L107

Latest holder period

n/a

13F holders

13D/G owners

0

CIK / CUSIP context first

BNR full holder history Burning Rock Biotech Ltd SEC filings Burning Rock Biotech Ltd company facts Burning Rock Biotech Ltd insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q4 0 $0 -$64,484 0
2024 Q3 21,212 $64,484 -$761 $3.04 1
2024 Q2 22,097 $136,094 -$16,092,890 $3.62 2
2024 Q1 20,649,684 $15,057,860 +$402,638 $0.73 20
2023 Q4 20,064,461 $18,682,043 -$666,244 $0.93 19
2023 Q3 20,753,481 $20,117,008 -$734,856 $0.97 27
2023 Q2 21,379,023 $46,159,776 -$939,058 $2.15 31
2023 Q1 21,663,295 $60,814,324 -$819,632 $2.81 32
2022 Q4 22,069,051 $49,630,619 -$3,239,921 $2.25 40
2022 Q3 23,231,970 $55,465,986 -$4,349,805 $2.39 47
2022 Q2 24,767,928 $71,168,352 -$30,970,776 $2.91 48
2022 Q1 29,510,597 $274,402,530 +$18,724,219 $9.29 43
2021 Q4 25,495,461 $241,308,981 -$36,609,937 $9.53 57
2021 Q3 27,470,929 $491,180,341 +$4,753,957 $17.88 82
2021 Q2 26,920,427 $792,304,929 +$102,643,853 $29.46 79
2021 Q1 23,578,976 $634,746,122 +$86,851,459 $26.92 51
2020 Q4 20,526,046 $474,167,436 +$99,408,578 $23.10 57
2020 Q3 15,975,265 $400,530,030 +$3,105,150 $25.08 38
2020 Q2 15,781,393 $426,251,845 +$426,251,845 $27.01 47
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .